WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck & Co., Inc. announced today that, subject to final review of its first-quarter results, it anticipates its first-quarter earnings per share (EPS) will be $0.84, excluding restructuring charges related to site closures and position eliminations, and its reported EPS will be $0.78. Merck attributed these anticipated results to strong revenue performance across the Company’s range of products. The Company also raised its anticipated 2007 full-year EPS range to $2.75 to $2.85, excluding restructuring charges related to site closures and position eliminations, and its full-year 2007 reported EPS range to $2.60 to $2.75.
